Log In
Log In
Client Account Access
Equity Research Access
Fixed Income Client Portal
Macro Research Access
Merchant Banking Investor Access
Main navigation
What We Do
What We Do
Investment Banking
Public Finance
Research
Fixed Income
Alternative Asset Management
Equities
Sectors
Sectors
Chemicals
Consumer
Education
Energy & Power
Financial Services
Financial Sponsors
Government
Healthcare
Real Estate
Services & Industrials
Technology
About
About
Who We Are
Our Commitments
Our People
Insights
News
Conferences & Events
Careers
Investor Relations
Transactions
Transactions
Investment Banking
Public Finance
Contact
Search
Invalid search inquiry
Read more
about DesignTherapeutics-2021-03-25
$276.0 Million
Image
Design Therapeutics
Initial Public Offering
Active Bookrunner
Read more
about ReneoPharmaceuticals-2021-04-08
$93.7 Million
Image
Reneo Pharmaceuticals
Initial Public Offering
Active Bookrunner
Read more
about TalisBiomedical-2021-02-11
$253.9 Million
Image
Talis Biomedical
Initial Public Offering
Active Bookrunner
Read more
about SenseiBiotherapeuticsInc-2021-02-03
$152.5 Million
Image
Sensei Biotherapeutics, Inc.
Initial Public Offering
Active Bookrunner
Read more
about AkoyaBiosciencesInc-2021-04-15
$151.3 Million
Image
Akoya Biosciences, Inc.
Initial Public Offering
Active Bookrunner
Read more
about ConnectBiopharma-2021-03-18
$219.9 Million
Image
Connect Biopharma
Initial Public Offering
Active Bookrunner
Read more
about RainTherapeutics-2021-04-22
$124.9 Million
Image
Rain Therapeutics
Initial Public Offering
Active Bookrunner
Read more
about AchillesTherapeutics-2021-03-30
$175.0 Million
Image
Achilles Therapeutics
Initial Public Offering
Active Bookrunner
Read more
about GracellBio-2021-01-07
$240.0 Million
Image
Gracell Bio
Initial Public Offering
Active Bookrunner
Read more
about KronosBio-2020-10-08
$287.5 Million
Image
Kronos Bio
Initial Public Offering
Active Bookrunner
Pagination
Previous page
‹‹
Page 13
Next page
››
Subscribe to Active Bookrunner